Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Effect of acute Chlamydia pneumoniae infection on lipoprotein metabolism in NIH/S mice.

Tiirola T, Erkkilä L, Laitinen K, Leinonen M, Saikku P, Bloigu A, Jauhiainen M.

Scand J Clin Lab Invest. 2002;62(6):477-84.

PMID:
12469903
2.

Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis.

Laurila A, Bloigu A, Näyhä S, Hassi J, Leinonen M, Saikku P.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2910-3.

PMID:
9409275
3.

[Establishment and experimental study on mouse model of Chlamydia pneumoniae pneumonitis].

Shi Y, Yin J, Zhan H.

Zhonghua Jie He He Hu Xi Za Zhi. 2001 Oct;24(10):592-5. Chinese.

PMID:
11770419
4.

Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.

Aalto-Setälä K, Laitinen K, Erkkilä L, Leinonen M, Jauhiainen M, Ehnholm C, Tamminen M, Puolakkainen M, Penttilä I, Saikku P.

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):578-84.

PMID:
11304476
5.

Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.

Törmäkangas L, Erkkilä L, Korhonen T, Tiirola T, Bloigu A, Saikku P, Leinonen M.

Infect Immun. 2005 Oct;73(10):6458-66.

6.

Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice.

Marangoni A, Fiorino E, Gilardi F, Aldini R, Scotti E, Nardini P, Foschi C, Donati M, Montagnani M, Cevenini M, Franco P, Roda A, Crestani M, Cevenini R.

Atherosclerosis. 2015 Aug;241(2):471-9. doi: 10.1016/j.atherosclerosis.2015.05.023. Epub 2015 Jun 3.

PMID:
26086356
7.

Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung.

Burián K, Hegyesi H, Buzás E, Endrész V, Kis Z, Falus A, Gönczöl E.

Immunol Lett. 2003 Oct 31;89(2-3):229-36.

PMID:
14556983
8.

[Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease].

Duan Z, Liu S, Wang B.

Zhonghua Jie He He Hu Xi Za Zhi. 2001 Apr;24(4):208-11. Chinese.

PMID:
11802964
9.

Experimental infection of Chlamydia pneumoniae in mice.

Kaukoranta-Tolvanen SS, Laurila AL, Saikku P, Leinonen M, Liesirova L, Laitinen K.

Microb Pathog. 1993 Oct;15(4):293-302.

PMID:
8309355
11.

Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis.

Leinonen M, Saikku P.

Am Heart J. 1999 Nov;138(5 Pt 2):S504-6.

PMID:
10539859
12.
13.

Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice.

Ezzahiri R, Nelissen-Vrancken HJ, Kurvers HA, Stassen FR, Vliegen I, Grauls GE, van Pul MM, Kitslaar PJ, Bruggeman CA.

Cardiovasc Res. 2002 Nov;56(2):269-76.

PMID:
12393097
14.

Gene therapy with lipopolysaccharide binding protein for gram-negative pneumonia: respiratory physiology.

Hemmila MR, Kim J, Sun JM, Cannon J, Arbabi S, Minter RM, Su GL, Remick DG, Wang SC.

J Trauma. 2006 Sep;61(3):598-605; discussion 605-6.

PMID:
16966994
15.

Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats.

Wasan KM, Subramanian R, Kwong M, Goldberg IJ, Wright T, Johnston TP.

J Pharm Pharm Sci. 2003 May-Aug;6(2):189-97.

16.

Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT, Kuo CC.

J Infect Dis. 1999 Jul;180(1):238-41.

PMID:
10353889
17.

The pathogenesis of Chlamydia pneumoniae-type pneumonitis in mice.

Shi Y, Yin J, Zhan H, Feng G, Zhang X, Su X, Song Y, Xia X, Zhou X, Shen P.

Chin Med J (Engl). 2003 Mar;116(3):328-32.

PMID:
12781030
18.

Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.

Wszola M, Kwiatkowski A, Nosek R, Podsiadly E, Meszaros J, Danielewicz R, Lisik W, Ostrowski K, Chmura A, Adadyński L, Paczek L, Durlik M, Tylewska-Wierzbanowska S, Rowiński W.

Transplant Proc. 2006 Jan-Feb;38(1):31-4.

PMID:
16504656
19.
20.

Enhanced cholesterol efflux promotion in well-trained soccer players.

Brites F, Verona J, De Geitere C, Fruchart JC, Castro G, Wikinski R.

Metabolism. 2004 Oct;53(10):1262-7.

PMID:
15375780

Supplemental Content

Support Center